RecruitingNCT04528498

Embryo Health Study

The Embryo Health Study: Prospective Longitudinal Analysis of PGT-P

Sponsor

Genomic Prediction Inc.

Enrollment

500 participants

Start Date

Dec 1, 2020

Study Type

OBSERVATIONAL

Conditions

Infertility Hereditary Diseases

Summary

This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Preimplantation Genetic Testing for people with hereditary diseases and infertility. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPreimplantation Genetic Testing

Embryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.